Additional file 4: of Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

Table S3. Relationship between tissue miR-196a level and clinicopathologic features in HNC; Table S4. Cox proportional hazards regression models for estimating overall survival related to Table S3. (DOC 86 kb)